brivaracetam 50 MG per 5 ML Injection
- RxCUI
- 1739749
- RxNorm name
- brivaracetam 50 MG per 5 ML Injection
- Display name
- brivaracetam 50 MG per 5 ML Injection
- Full name
- brivaracetam 50 MG per 5 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Briviact | BRIVARACETAM | UCB, Inc. | 3cf2f439-0e97-443e-8e33-25ecef616f6c | 2026-08-20 | Warnings, Adverse reactions | 1739749 |
| BRIVARACETAM | BRIVARACETAM | Micro Labs Limited | c054a1c9-2aa7-473b-a04b-622596f36c95 | 2026-02-24 | Warnings, Adverse reactions | 1739749 |
| Brivaracetam | BRIVARACETAM | Novadoz Pharmaceuticals LLC | 2c6af271-3222-4602-98a6-14754f0a29ba | 2026-02-23 | Warnings, Adverse reactions | 1739749 |
| Brivaracetam | BRIVARACETAM | Hainan Poly Pharm. Co., Ltd. | 3ea51292-fe03-46f5-9d9b-36986f5b7224 | 2026-02-23 | Warnings, Adverse reactions | 1739749 |
| Brivaracetam | BRIVARACETAM INJECTION | PAI Holdings, LLC dba PAI Pharma | 5bc0f4c0-8b31-4622-849f-d902be93788b | 2026-02-23 | Warnings, Adverse reactions | 1739749 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3cf2f439-0e97-443e-8e33-25ecef616f6c | brivaracetam 50 MG in 5 ML Injection [PSN] · 5 ML brivaracetam 10 MG/ML Injection [SCD] · brivaracetam 50 MG per 5 ML Injection [SY] | 3 | 26 | These highlights do not include all the information needed to use BRIVIACT ® safely and effectively. See full prescribing information for BRIVIACT. BRIVIACT ® (brivaracetam) tablets, for oral use, CV BRIVIACT ® (brivaracetam) oral solution, CV BRIVIACT ® (brivaracetam) injection, for intravenous use, CV Initial U.S. Approval: 2016 | 20260513 |
| 5bc0f4c0-8b31-4622-849f-d902be93788b | brivaracetam 50 MG in 5 ML Injection [PSN] · 5 ML brivaracetam 10 MG/ML Injection [SCD] · brivaracetam 50 MG per 5 ML Injection [SY] | 3 | 3 | These highlights do not include all the information needed to use BRIVARACETAM INJECTION safely and effectively. See full prescribing information for BRIVARACETAM INJECTION BRIVARACETAM injection, for intravenous use, CV Initial U.S. Approval: 2016 | 20260223 |
| c054a1c9-2aa7-473b-a04b-622596f36c95 | brivaracetam 50 MG in 5 ML Injection [PSN] · 5 ML brivaracetam 10 MG/ML Injection [SCD] · brivaracetam 50 MG per 5 ML Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use BRIVARACETAM INJECTION safely and effectively. See full prescribing information for BRIVARACETAM INJECTION. BRIVARACETAM injection, for intravenous use, CV Initial U.S. Approval: 2016 | 20260224 |
| 2c6af271-3222-4602-98a6-14754f0a29ba | brivaracetam 50 MG in 5 ML Injection [PSN] · 5 ML brivaracetam 10 MG/ML Injection [SCD] · brivaracetam 50 MG per 5 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use BRIVARACETAM INJECTION safely and effectively. See full prescribing information for BRIVARACETAM INJECTION. BRIVARACETAM injection, for intravenous use, CV Initial U.S. Approval: 2016 | 20260223 |
| 3ea51292-fe03-46f5-9d9b-36986f5b7224 | brivaracetam 50 MG in 5 ML Injection [PSN] · 5 ML brivaracetam 10 MG/ML Injection [SCD] · brivaracetam 50 MG per 5 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use BRIVARACETAM INJECTION safely and effectively. See full prescribing information for BRIVARACETAM INJECTION. BRIVARACETAM injection, for intravenous use, CV Initial U.S. Approval: 2016 | 20260223 |